IonQ (IONQ) files Registration Rights Agreement, Oct 2025

IonQ, Inc. filed an Form 8-K reporting several non-financial items including an Unregistered Sale of Equity Securities and governance changes.

Rhea-AI Filing Summary

IonQ, Inc. filed an Form 8-K reporting several non-financial items including an Unregistered Sale of Equity Securities and governance changes. The filing lists a Registration Rights Agreement dated October 2, 2025 between IonQ, Inc. and Fortis Advisors LLC, and it includes a Press Release dated October 7, 2025 as an exhibit. The document is signed by Paul T. Dacier, Chief Legal Officer and Corporate Secretary. The 8-K identifies Items 3.02, 5.02, 7.01, 8.01 and 9.01 but does not disclose transaction economics, share counts, or financial impacts within the provided text.

Positive

• Registration Rights Agreement executed on October 2, 2025 with Fortis Advisors LLC
• Press release filed as an exhibit on October 7, 2025, ensuring public disclosure

Negative

• No economic terms disclosed in the provided text—no share counts, proceeds, or dilution figures
• Items cited (3.02, 5.02, 7.01) lack accompanying detail here, limiting investor assessment

Insights

Capital Markets Analyst

Registration rights and press release indicate a financing or secondary transaction requiring disclosure.

The listing of a Registration Rights Agreement with Fortis Advisors LLC and the inclusion of Item 3.02 (unregistered sales) signal that equity was issued or will be registered, which can affect outstanding share float and future liquidity.

Key dependencies are the agreement's terms (timing, number of shares, underwriting) and any forward-looking statements in the October 7, 2025 press release; absent those details, near-term impacts on dilution or proceeds are unclear. Monitor the full exhibits for share counts and registration schedules.

Corporate Governance Attorney

The 8-K cites governance and disclosure items but provides only exhibit references, not substantive contract terms.

Item citations (5.02, 7.01, 8.01) suggest director/officer changes and Regulation FD disclosure may be relevant; however, the filing text here only enumerates those items and the exhibits rather than describing specific departures or appointments.

Investors should review the attached Registration Rights Agreement and the October 7, 2025 press release to confirm any director changes, compensatory arrangements, or selective disclosures referenced by Item 7.01.

8-K Event Classification

3 items: 3.02, 7.01, 8.01

3 items

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IonQ (IONQ) disclose in this 8-K?

The 8-K lists a Registration Rights Agreement dated October 2, 2025 with Fortis Advisors LLC and includes a Press Release dated October 7, 2025; the filing cites Items 3.02, 5.02, 7.01, 8.01 and 9.01.

Does the filing state how many shares were sold or proceeds raised?

No. The provided text does not disclose share counts, proceeds, or other economic terms.

Was any officer or director change described in the 8-K?

The filing cites Item 5.02 (departures/elections/appointments) but the excerpt does not include specific names or descriptions beyond the signature of Paul T. Dacier.

Where can I find the agreement and press release referenced?

The Registration Rights Agreement (Exhibit 10.1) and the Press Release (Exhibit 99.1) are listed as exhibits to the 8-K; review those exhibits for full terms and statements.

Who signed the 8-K for IonQ?

The filing is signed by Paul T. Dacier, Chief Legal Officer and Corporate Secretary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/07/2025 - 08:19 AM EDT Learn about SEC filing dates

false 0001824920 0001824920 2025-10-01 2025-10-01 0001824920 IONQ:CommonStockParValue0.00001PerShareMember 2025-10-01 2025-10-01 0001824920 IONQ:DepositarySharesEachRepresenting120thInterestInShareOf5.50SeriesBMandatoryConvertiblePreferredStockParValue0.001PerShareMember 2025-10-01 2025-10-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 1, 2025

IonQ, Inc.

(Exact name of registrant as specified in its charter)

Delaware	001-39694	85-2992192
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

4505 Campus Drive
College Park, Maryland
(Address of principal executive offices) 20740
(Zip Code)

Registrant’s telephone number, including area code: 301-298-7997

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.0001 per share		IONQ		New York Stock Exchange
Warrants, each exercisable for one share of common stock for $11.50 per share		IONQ WS		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth under Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. The issuance and sale of shares of IonQ, Inc. (the “Company”) common stock in connection with the Transaction (as defined below) was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or the private offering provision of Rule 506 of Regulation D.

Item 5.02 Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Bill Scannell’s resignation from the Board and his concurrent assumption of the role of Senior Commercial Advisor, which was previously disclosed as being expected in connection with the appointment of General John W. Raymond to the Board, occurred on October 1, 2025.

Item 7.01 Regulation FD Disclosure.

On October 7, 2025, the Company issued a press release announcing the completion of the Transaction. A copy of the press release has been furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information provided pursuant to Item 7.01 of this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company’s filings under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 8.01 Other Events.

On October 2, 2025, the Company completed its previously announced transaction (the “Transaction”) to acquire all of the issued and outstanding shares of Vector Atomic, Inc., a California corporation (“Vector Atomic”), pursuant to the terms of the Agreement and Plan of Merger, dated September 16, 2025, by and among the Company, Vector Atomic, Violin Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company and Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as the agent, representative and attorney-in-fact on behalf of the stockholders of Vector Atomic (the “Securityholder Representative”). The aggregate consideration delivered at the closing of the Transaction consisted of 6,080,379 shares of the Company’s common stock (the “Stock Consideration”).

In connection with the closing of the Transaction and in connection with the issuance of the Stock Consideration, the Company and the Securityholder Representative entered into a Registration Rights Agreement, dated October 2, 2025 (the “Registration Rights Agreement”), pursuant to which the stockholders of Vector Atomic will have certain registration rights relating to the Stock Consideration.

The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such Registration Rights Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1		Registration Rights Agreement, dated as of October 2, 2025, by and between IonQ, Inc. and Fortis Advisors LLC.
99.1		Press Release, dated October 7, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	IonQ, Inc.
Date: October 7, 2025	By:	/s/ Paul T. Dacier
		Paul T. Dacier
		Chief Legal Officer and Corporate Secretary